Zota Health Care Stock Hits All-Time High at Rs.1640 Mark

Nov 19 2025 10:58 AM IST

Share Via

Zota Health Care has reached a significant milestone by hitting an all-time high of Rs.1640 today, marking a notable event in the Pharmaceuticals & Biotechnology sector. This achievement reflects the company’s sustained performance across multiple time frames and its ability to outperform key market benchmarks.

Zota Health Care’s stock price today recorded a gain of 4.59%, considerably outpacing the Sensex’s modest rise of 0.26%. This surge places the stock well above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a strong upward momentum in the short to long term. The company’s market capitalisation grade stands at 3, indicating a mid-tier valuation within its sector.

Examining the stock’s performance over various periods highlights its robust trajectory. Over the past week, Zota Health Care’s stock appreciated by 7.46%, compared to the Sensex’s 0.50% gain. The one-month performance shows an 8.16% increase against the Sensex’s 1.12%, while the three-month figure stands at 22.73%, significantly ahead of the Sensex’s 3.97% rise.

Looking at the longer-term performance, Zota Health Care’s stock has demonstrated exceptional growth. The one-year performance shows a remarkable 196.87% increase, vastly outperforming the Sensex’s 9.42% gain during the same period. Year-to-date figures reveal a 105.58% rise for the stock, compared to the Sensex’s 8.64%. Over three years, the stock’s appreciation reaches 525.84%, while the Sensex recorded a 37.67% increase.

Over a five-year horizon, Zota Health Care’s stock price has surged by 1085.67%, a figure that dwarfs the Sensex’s 94.70% gain. It is notable that the 10-year performance data for Zota Health Care is not available, whereas the Sensex has recorded a 228.50% increase over the same period.

The company’s Mojo Score currently stands at 40.0, with a Mojo Grade of Sell as of 5 May 2025, following a revision from a previous Strong Sell grade. This adjustment in evaluation reflects changes in the company’s underlying metrics and market conditions as of the trigger date 19 November 2025, coinciding with the all-time high event.

In terms of sector comparison, Zota Health Care’s performance today outpaced the Pharmaceuticals & Biotechnology sector by 4.39%, underscoring its relative strength within the industry. The stock’s consistent trading above all major moving averages further supports the view of sustained positive momentum.

While the stock’s market capitalisation grade of 3 places it in a moderate valuation bracket, its price performance over multiple time frames highlights a strong growth pattern. The substantial gains over one, three, and five years indicate that the stock has been a significant outperformer relative to the broader market and sector indices.

Overall, Zota Health Care’s attainment of an all-time high at Rs.1640 represents a key milestone in its market journey. The data-driven analysis of its price movements and comparative performance metrics provides a clear picture of the company’s standing in the Pharmaceuticals & Biotechnology sector as of November 2025.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE